Risk Stratification for Sarcopenic Obesity in Nonalcoholic Fatty Liver Disease
Clinical Gastroenterology and Hepatology · 2023-10 · 21 (11) · 2984
DOI: 10.1016/j.cgh.2023.02.012 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-10. Verfasst von Rongtao Lai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California; Department of Infectious Diseases, Ruijin Hos…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Sarcopenia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Chin…
- Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California; Department of Epidemiology and Population Health, Stanford University, Palo Alto, California. Electronic address: m…
Zitieren
APA
Lai, R., & Nguyen, M. H. (2023). Risk Stratification for Sarcopenic Obesity in Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology, 21(11), 2984. https://doi.org/10.1016/j.cgh.2023.02.012
Vancouver
Lai R, Nguyen MH. Risk Stratification for Sarcopenic Obesity in Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology. 2023;21(11):2984. doi:10.1016/j.cgh.2023.02.012
BibTeX
@article{Lai2023,
author = {Lai, Rongtao and Nguyen, Mindie H},
title = {Risk Stratification for Sarcopenic Obesity in Nonalcoholic Fatty Liver Disease},
journal = {Clinical Gastroenterology and Hepatology},
year = {2023},
volume = {21},
number = {11},
pages = {2984},
doi = {10.1016/j.cgh.2023.02.012}
}
EUVIMED